NVCT
Nuvectis Pharma Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$9.03
+0.01 ▲ +0.11%
🌙 3월 13일 4:04 PM ET (한국 3/14 05:04)
$9.03
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -1.28 | Insider Own | 44.26% | Shs Outstand | 0.03B | Perf Week | 0.78% |
| Market Cap | 0.24B | Forward P/E | - | EPS next Y | -3.95% | Insider Trans | 1.59% | Shs Float | 0.01B | Perf Month | 2.85% |
| Enterprise Value | 0.21B | PEG | - | EPS next Q | -0.31 | Inst Own | 16.06% | Short Float | 10.97% | Perf Quarter | 22.19% |
| Income | -0.03B | P/S | - | EPS this Y | 4.09% | Inst Trans | 7.57% | Short Ratio | 24.35 | Perf Half Y | 38.71% |
| Sales | 0.00B | P/B | 12.59 | EPS next 5Y | 4.33% | ROA | -114.76% | Short Interest | 1.62M | Perf YTD | 19.6% |
| Book/sh | 0.72 | P/C | 7.56 | EPS past 3/5Y | 4.25% -340.28% | ROE | -205.3% | 52W High | -21.61% ($11.52) | Perf Year | 8.14% |
| Cash/sh | 1.19 | P/FCF | - | Sales past 3/5Y | - | ROIC | -156.8% | 52W Low | 62.7% ($5.55) | Perf 3Y | -9.15% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -19.41% | Gross Margin | - | Volatility(W/M) | 4.97% 4.85% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.44 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.38 | EPS Q/Q | 11.14% | Profit Margin | - | RSI (14) | 53.36 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.38 | Sales Q/Q | - | SMA20 | 1.4% ($8.91) | Beta | -0.31 | Target Price | $16.8 |
| Payout | - | Debt/Eq | 0 | Earnings | 2000000 | SMA50 | 4.23% ($8.66) | Rel Volume | 0.46 | Prev Close | $9.02 |
| Employees | 13 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 1.9% - | SMA200 | 22.1% ($7.4) | Avg Volume(3M) | 0.07M | Price | $9.03 |
| IPO | 2022/2/4 | Option/Short | Yes/Yes | Trades | 446 | Volume | 30,400 | Change | 0.11% |
뉴스 로딩 중...